Filana Therapeutics, Inc. Increase (Decrease) in Accounts Receivable
Filana Therapeutics, Inc. (FLNA) reported Increase (Decrease) in Accounts Receivable of -$7.11 million for the 12-month period ending 2011-12-31, per its 10-K filed 2014-02-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2014-02-05
- Filana Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2011-12-31 was -$640.00K.
- Filana Therapeutics, Inc. increase (decrease) in accounts receivable for the quarter ending 2011-09-30 was -$199.00K.
- Filana Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2011 was -$7.11M, a 247.84% decline from fiscal 2010.
- Filana Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2010 was $4.81M, a 128.71% increase from fiscal 2009.
- Filana Therapeutics, Inc. increase (decrease) in accounts receivable for fiscal 2009 was $2.10M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2011-12-31 | -$640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-05 | -$839.00K derived: sum of 2 quarters · filed 2014-02-05 | -$7.11M 10-K · filed 2014-02-05 | |
| 2011-09-30 | -$199.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$6.47M 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | -$6.28M 10-Q · filed 2012-08-02 | |||
| 2010-12-31 | $4.81M 10-K · filed 2013-02-08 | |||
| 2009-12-31 | $2.10M 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |